Effects of methylphenidate on intelligence and attention components in boys with attention-deficit/hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 21, Issue 3, 2011, Pages 245-253

  Hellwig Brida, Susanne ^a   Daseking, Monika ^b   Keller, Ferdinand ^a   Petermann, Franz ^b   Goldbeck, Lutz ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CHILD; COGNITION; COMPREHENSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTELLIGENCE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRESCHOOL CHILD; PSYCHOMETRY; SCHOOL CHILD; TEST OF ATTENTIONAL PERFORMANCE FOR CHILDREN; TREATMENT OUTCOME; VERBAL BEHAVIOR; WECHSLER INTELLIGENCE SCALE; WORKING MEMORY;

ADOLESCENT; ANALYSIS OF VARIANCE; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COGNITION; FOLLOW-UP STUDIES; HUMANS; INTELLIGENCE TESTS; MALE; METHYLPHENIDATE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; TIME FACTORS;

EID: 79958834795     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2010.0041     Document Type: Article

References (68)

1. Aman M, Turbott SH: Prediction of clinical response in children taking methylphenidate. J Autism Dev Disord 21:211-228, 1991.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
3. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Dankaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJS, Taylor E: Langwirksame Medikamente zur Behandlung der hyperkinetischen Störungen. Eine systematische Ü bersicht und europäische Leitlinien. Teil1: Ü bersicht und Empfehlungen. [Long-acting medications for the treatment of hyperkinetic disorders-A systematic review and European treatment guideline. Part 1: overview and recommendations] Z Kinder Jugendpsychiatr Psychother 36:81-95, 2008.
4. Barkley RA: Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 121:65-94, 1997. (Pubitemid 127705285)
5. Bedard AC, Ickowicz A, Tannock R: Methylphenidate improves Stroop naming speed, but not response interference, in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 12:301-309, 2002. (Pubitemid 36169282)
6. Bedard AC, Jain U, Johnson SH, Tannock R: Effects of methylphenidate on working memory components: Influence of measurement. J Child Psychol Psychiatry 48:872-880, 2007. (Pubitemid 47244900)
7. Biederman J: Attention-deficit/hyperactivity disorder: A selective overview. Biol Psychiatry 57:1215-1220, 2005. (Pubitemid 40798537)
8. Boonstra AM, Kooij JJS, Oosterlaan J, Sergeant JA, Buitelaar JK: Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD? J Clin Exp Neuropsychol 27:278-298, 2005. (Pubitemid 40523416)
9. Chamberlain SR, Sahakian BJ: The neuropsychiatry of impulsivity. Curr Opin Psychiatry 20:255-261, 2007. (Pubitemid 46588298)
10. Chhabildas N, Pennington BF, Willcutt EG: A comparison of the neuropsychological profiles of the DSM-IV subtypes of ADHD. J Abnorm Child Psychol 29:529-540, 2001. (Pubitemid 33745787)
11. Coghill DR, Rhodes SM, Matthews K: The neuropsychological effects of chronic methylphenidate on drug-na?̈ve boys with attentiondeficit/ hyperactivity disorder. Biol Psychiatry 62:954-962, 2007. (Pubitemid 47562365)
12. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988.
13. DAgostino RB: Tutorial in biostatistics. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265-2281, 1998.
14. Döpfner M, Görtz-Dorten A, Lehmkuhl G, Breuer D, Goletz H: DISYPS-II. Diagnostik-System für psychische Störungen nach ICD-10 und DSM-IV für Kinder und Jugendliche - II. Manual. [Diagnostic System for Mental Disorders in Children and Adolescents, 2nd ed.]. Bern: Huber; 2008.
15. Döpfner M, Lehmkuhl G: DISYPS-KJ. Diagnostik-System für psychische Störungen im Kindes- und Jugendalter nach ICD-10 und DSM-IV. Klinische Diagnostik - Elternurteil - Lehrerurteil - Selbsturteil. Manual. [Diagnostic System for mental disorders in Children and Adolescents According to ICD-10 and DSM IV]. Bern: Huber, 2000.
16. Drechsler R, Rizzo P, Steinhausen HC: Zur klinischen Validität einer computerunterstützten Aufmerksamkeitstestbatterie für Kinder (KITAP) bei 7-10jährigen Kindern mit ADHS. [The clinical validity of a computerized test battery for attentional performance for children (KITAP) in the diagnosis of ADHD in children aged 7-10 years] Kindh Entwickl 18:153-161, 2009.
17. Epstein JN, Conners CK, Hervey AS, Tonev ST, Arnold LE, Abikoff HB, Elliott G, Greenhill LL, Hechtman L, Hoagwood K, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Wells K, Vitiello B, Wigal T: MTA Cooperative Study Group. Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry 47:446-456, 2006.
18. Eslinger PJ, Grattan LM: Frontal lobe and frontal-striatal substrates for different forms of human cognitive flexibility. Neuropsychologia 31:17-28, 1993. (Pubitemid 23068960)
19. Faraone S, Sergeant J, Gillberg C, Biederman J: The worldwide prevalence of ADHD: Is it an American disorder? World Psychiatry 2:104-113, 2003.
20. Francis S, Fine J, Tannock R: Methylphenidate selectivity improves story retelling in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 11:217-228, 2001. (Pubitemid 32937634)
21. Fry AF, Hale S: Relationships among processing speed, working memory and fluid intelligence in children. Biol Psychol 54:1-34, 2000.
22. Gershon J: A meta-analytic review of gender differences in ADHD. J Atten Disord 5:143-154, 2002. (Pubitemid 44844210)
23. Goldbeck L, Daseking M, Hellwig-Brida S, Waldmann H, Petermann F: Sex differences on the German Wechsler Intelligence Test for Children (WISC-IV). J Individ Differences 31:22-28, 2010.
24. Harder VS, Stuart, EA, Anthony JC: Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research. Psychol Methods 15:234-249, 2010.
25. Hausknecht JP, Halpert JA, Di Paolo NT, Moriarty Gerrard MO: Retesting in selection: A meta-analysis of coaching and practice effects for tests of cognitive ability. J Appl Psychol 92:373-385, 2007.
26. Holm S: A simple sequentially rejective multiple test procedure. Scand J Stat 6:65-70, 1979.
27. Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C: Executive function and attention deficit hyperactivity disorder: Stimulant medication and better executive function performance in children. Psychol Med 29:527-538, 1999. (Pubitemid 29261342)
28. Konrad K, Gunther T, Hanisch C, Herpertz-Dahlmann B: Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 43:191-198, 2004.
29. Konrad K, Gunther T, Heinzel-Gutenbrunner M, Herpertz-Dahlmann B: Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial. J Child Adolesc Psychopharmacol 15:180-190, 2005.
30. Koschack J, Kunert HJ, Derichs G, Weniger G, Irle E: Impaired and enhanced attentional function in children with attention deficit/hyperactivity disorder. Psychol Med 33:481-489, 2003. (Pubitemid 36442790)
31. Lajoie G, Anderson V, Anderson P, Tucker AR, Robertson IH, Manly T: Effects of methylphenidate on attention skills in children with attention deficit/hyperactivity disorder. Brain Impairment 6:21-32, 2005.
32. LipsiusM, Petermann F: Vergleich zwischen HAWIK-III und HAWIKIV für den Testanwender. [A comparison of the German WISC-III and WISC-IV for practitioners] Diagnostica 55:255-261, 2009.
33. Losier BJ, McGrath PJ, Klein RM: Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: A meta-analytic review. J Child Psychol Psychiatry 37:971-987, 1996. (Pubitemid 26397633)
34. McInnes A, Bedard AC, Hogg-Johnson S, Tannock R: Preliminary evidence of beneficial effects of methylphenidate on listening comprehension in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17:35-49, 2007. (Pubitemid 46452080)
35. Pennington BF, Ozonoff S: Executive functions and developmental psychopathology. J Child Psychol Psychiatry 37:51-87, 1996. (Pubitemid 26090587)
36. Petermann F, Petermann U: Hamburg-Wechsler Intelligenztest für Kinder - HAWIK-IV. [Wechsler Intelligence Scale for Children- German Version]. Bern: Huber, 2007.
37. Petermann F, Petermann U: HAWIK-IV. [WISC-IV] Kindh Entwickl 17:71-75, 2008.
38. Pietrzak RH, Mollica CM, Maruff P, Snyder PJ: Cognitive effects of immediate-release methylphenidate in children with attention-deficit/ hyperactivity disorder. Neurosci Biobehav Rev 30:1225-1245, 2006. (Pubitemid 44855160)
39. Pliszka SR: The neuropsychopharmacology of attention-deficit/ hyperactivity disorder. Biol Psychiatry 57:1385-1390, 2005.
40. Pliszka SR, Glahn DC, Semrud-Clikeman M, Franklin C, Perez RI, Xiong J, Liotti M: Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment. Am J Psychiatry 163:1052-1060, 2006. (Pubitemid 44464492)
41. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA: The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 164:942-948, 2007. (Pubitemid 46972911)
42. Reid MK, Borkowski JG: Effects of methylphenidate (Ritalin) on information processing in hyperactive children. J Abnorm Child Psychol 12:169-185, 1984.
43. Rhodes S, Coghill D, Matthews K: Acute neuropsychological effects of methylphenidate in stimulant drug-naive boys with ADHD II-broader executive and non-executive domains. J Child Adolesc Psychopharmacol 47:1184-1194, 2006. (Pubitemid 44660621)
44. Riccio CA, Waldrop JJ, Reynolds CR, Lowe P: Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 13:326-335, 2001. (Pubitemid 32743710)
45. Rosenbaum PR, Rubin DV: The central role of the propensity score in observational studies of causal effects. Biometrica 70:41-55, 1983.
46. Santosh PJ, Taylor E: Stimulant drugs. Eur Child Adolesc Psychiatry 9:I27-I43, 2000.
47. Schafer JL, Kang J: Average causal effects from nonrandomized studies: A practical guide and simulated example. Psychol Methods 13:279-313, 2008.
48. Scheres A, Oosterlaan J, Swanson J, Morein-Zamir S, Meiran N, Schut H, Vlasveld L, Sergeant J: The effect of methylphenidate on three forms of response inhibition in boys with ADHD. J Abnorm Child Psychol 31:105-120, 2003. (Pubitemid 36578355)
49. Schlack R, Hölling H, Kurth B-M, Huss M: Die Prävalenz der Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (ADHS) bei Kindern und Jugendlichen in Deutschland. [The prevalence of attentiondeficit/ hyperactivity disorder (ADHD) among children and adolescents in Germany. Initial results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)] Bundesgesundheitsblatt 50:827-835, 2007.
50. Schulz KF, Altman DG, Moher D, for the CONSORT Group. Research Methods and Reporting CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Obstet Gynecol 115:1063-1070, 2010.
51. Schweizer K, Moosbrugger H, Goldhammer F: The structure of the relationship between attention and intelligence. Intelligence 33:589-611, 2005. (Pubitemid 41644267)
52. Sergeant JA: Modeling attention-deficit/hyperactivity disorder: A critical appraisal of the cognitive-energetic model. Biol Psychiatry 57:1248-1255, 2005. (Pubitemid 40798542)
53. Shanahan MA, Pennington BF, Yerys BE, Scott A, Boada R, Willcutt EG, Olson RK, DeFries JC: Processing speed deficits in attention deficit/hyperactivity disorder and reading disability. J Abnorm Child Psychol 34:585-602, 2006.
54. Sprague RL, Sleator EK: Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science 198:1274-1276, 1977. (Pubitemid 8308550)
55. Sturm W, de Simone A, Krause BJ, Specht K, Hesselmann V, Radermacher I, Herzog H, Tellmann L, Muller-Gartner HW, Willmes K: Functional anatomy of intrinsic alertness: Evidence for a fronto-parietal-thalamic-brainstem network in the right hemisphere. Neuropsychologia 37:797-805, 1999. (Pubitemid 29245978)
56. Tannock R, Ickowicz A, Schachar R: Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 34:886-896, 1995.
57. Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga- Barke EJ, Steinhausen HC, Zuddas A: European clinical guidelines for hyperkinetic disorder-first upgrade. Eur Child Adolesc Psychiatry 13 Suppl 1:17-30, 2004.
58. Tucha O, Prell S, Mecklinger L, Bormann-Kischkel C, Kuebber S, Linder M, Walitza S, Lange KW: Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder. Psychopharmacology 185:315-326, 2006.
59. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, Gabrieli JD: Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proc Natl Acad Sci U S A 95:14494-14499, 1998. (Pubitemid 28549395)
60. Van der Meere J, Gunning B, Stemerdink N: The effect of methylphenidate and clonidine on response inhibition and state regulation in children with ADHD. J Child Psychol Psychiatry 40:291-298, 1999. (Pubitemid 29078374)
61. van Zomeren AH, BrouwerWH: ClinicalNeuropsychology of Attention. New York: Oxford University Press; 1994.
62. Wechsler D: WISC-IV. Wechsler Intelligence Scale for Children-. Fourth Edition. Administration and Scoring Manual. San Antonio: The Psychological Corporation; 2003.
63. Whyte J, Hart T, Vaccaro M, Grieb-Neff P, Risser A, Polansky M, Coslett HB: Effects of methylphenidate on attention deficits after traumatic brain injury: A multidimensional, randomized, controlled trial. Am J Phys Med Rehabil 83:401-420, 2004. (Pubitemid 38658128)
64. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF: Validity of the executive function theory of attention-deficit/ hyperactivity disorder: A meta-analytic review. Biol Psychiatry 57: 1336-1346, 2005. (Pubitemid 40798553)
65. World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: American Psychiatric Publishing, Inc.; 1992.
66. Zeiner P: Response to methylphenidate in boys with attention-deficit hyperactivity disorder. Acta Paediatr 88:298-303, 1999. (Pubitemid 29144137)
67. Zimmermann P, Fimm B: Testbatterie zur Aufmerksamkeitsprüfung (TAP). [Test of Attentional Performance]. Herzogenrath: Vera Fimm Psychologische Testsysteme; 1992.
68. Zimmermann P, Gondan M, Fimm B: Testbatterie zur Aufmerksamkeitspru ̈fung für Kinder (KITAP) [Test of Attentional Performance for Children]. Herzogenrath: Vera Fimm Psychologische Testsysteme; 2002.